Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beran

Showing results (101-110 of 251) with videos related to

Pageof 26
Sort By:
Oncogene|January 1, 1989
Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemiaP Romero, M Beran, M Shtalrid, et al.
Oral Oncology|December 12, 2025
Treatment and outcome for 2,111 patients with vermilion lip squamous cell carcinoma: A nationwide, population-based study from the SweHNCRA Hafström, E Hammerlid, M Beran, et al.
Hematologic Pathology|January 1, 1987
The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observationsS O'Brien, H M Kantarjian, M Talpaz, et al.
Experimental Hematology|May 1, 1980
Effect of pyran copolymer on murine hemopoiesisA R Zander, G Spitzer, D S Verma, et al.
Differentiation; Research in Biological Diversity|November 1, 1991
Expression pattern of a hematopoietic proteoglycan core protein gene during human hematopoiesisC M Stellrecht, W M Mars, H Miwa, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
The tissue localization of m-AMSA and its effect on thymidine incorporation in various tissues in vivoB Hellman, B S Andersson, P Slanina, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1986
Analysis of nuclear m-AMSA content by DNA fluorochrome competitionB S Andersson, M Beran, B Barlogie, et al.
Biochemical and Biophysical Research Communications|April 29, 1987
The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugsE H Estey, L Silberman, M Beran, et al.
Leukemia Research|January 1, 1986
The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemiaM B Blick, B S Andersson, J U Gutterman, et al.
Blood|March 1, 1987
Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell linesM Beran, B S Andersson, P Kelleher, et al.
Pageof 26

Showing results (101-110 of 251) with videos related to

Sort By:
Pageof 26
Oncogene|January 1, 1989
Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemiaP Romero, M Beran, M Shtalrid, et al.
Oral Oncology|December 12, 2025
Treatment and outcome for 2,111 patients with vermilion lip squamous cell carcinoma: A nationwide, population-based study from the SweHNCRA Hafström, E Hammerlid, M Beran, et al.
Hematologic Pathology|January 1, 1987
The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observationsS O'Brien, H M Kantarjian, M Talpaz, et al.
Experimental Hematology|May 1, 1980
Effect of pyran copolymer on murine hemopoiesisA R Zander, G Spitzer, D S Verma, et al.
Differentiation; Research in Biological Diversity|November 1, 1991
Expression pattern of a hematopoietic proteoglycan core protein gene during human hematopoiesisC M Stellrecht, W M Mars, H Miwa, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
The tissue localization of m-AMSA and its effect on thymidine incorporation in various tissues in vivoB Hellman, B S Andersson, P Slanina, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1986
Analysis of nuclear m-AMSA content by DNA fluorochrome competitionB S Andersson, M Beran, B Barlogie, et al.
Biochemical and Biophysical Research Communications|April 29, 1987
The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugsE H Estey, L Silberman, M Beran, et al.
Leukemia Research|January 1, 1986
The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemiaM B Blick, B S Andersson, J U Gutterman, et al.
Blood|March 1, 1987
Diversity of the effect of recombinant tumor necrosis factors alpha and beta on human myelogenous leukemia cell linesM Beran, B S Andersson, P Kelleher, et al.
Pageof 26